Keyword Search Year None202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000 Date Title 04/03/2023 Heron Therapeutics Announces New CEO and Board Chairman 03/23/2023 Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2022 and Highlights Recent Corporate Updates 03/13/2023 Heron Therapeutics Announces Centers for Medicare & Medicaid Services (CMS) Granted Pass-through Payment Status for APONVIE™, Effective April 1, 2023 03/10/2023 Heron Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 23, 2023 03/06/2023 Heron Therapeutics Announces U.S. Commercial Launch of APONVIE™ for the Management of Postoperative Nausea and Vomiting in Adults 02/27/2023 Heron Therapeutics Announces Presentation at 43rd Annual Cowen Healthcare Conference 02/22/2023 Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital 01/09/2023 Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 18 of 18